A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL. - Ricard L; Cervera P; Stocker N; Corre E; Van de Wyngaert Z; Banet A; Marjanovic Z; Dulery R; Bravetti C; Joly AC; Baylatry MT; Coppo P (Frontiers in immunology, 2024)